• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
18.97
114440.73
EPS(TTM)
Face Value()
Div & Yield %
131.91
2
0.72
 

Sampre Nutritions reports consolidated net profit of Rs 1.35 crore in the March 2026 quarter
Jun 01,2026
Net profit of Sampre Nutritions reported to Rs 1.35 crore in the quarter ended March 2026 as against net loss of Rs 7.35 crore during the previous quarter ended March 2025. Sales rose 94.34% to Rs 15.10 crore in the quarter ended March 2026 as against Rs 7.77 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 3.08 crore in the year ended March 2026 as against net loss of Rs 7.67 crore during the previous year ended March 2025. Sales rose 72.57% to Rs 43.35 crore in the year ended March 2026 as against Rs 25.12 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales15.107.77 94 43.3525.12 73
OPM %2.85-80.69 -10.98-15.37 -
PBDT0.59-6.54 LP 3.82-5.55 LP
PBT0.05-7.21 LP 1.78-7.52 LP
NP1.35-7.35 LP 3.08-7.67 LP